Emergency thiola 100 MG tablets
Active Awarded Last action
- Contract number
- 36C26226N0373
- Awardee
-
Travere Therapeutics, Inc. UEI JUBZMHK84S36
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $131,523
Award facts
- Contract value 100% obligated
- $131,523.01 Current and potential, with all options
- Completion date 69% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92130, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a $131,523.01 firm fixed-price delivery order to Travere Therapeutics, Inc. for the supply of emergency Thiola 100 mg tablets. The delivery order, issued on February 10, 2026, is expected to be completed by February 9, 2027, and represents a task order issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This award carries no set-aside designation and will be performed in San Diego, California, where Travere maintains its headquarters and primary operations.
Travere Therapeutics is a biopharmaceutical company specializing in rare disease medications with an established track record as a critical supplier to the VA system. Thiola (tiopronin) is a core product in Travere's portfolio, used to treat cystinuria and related kidney disorders, and the company currently operates under two significant indefinite delivery vehicles with the VA—a Federal Supply Schedule contract and a $25 million Blanket Purchase Agreement, both expiring September 14, 2026. This delivery order exemplifies the VA's continued reliance on Travere for specialized pharmaceuticals essential to veteran healthcare, with the company having demonstrated consistent performance across multiple Veterans Integrated Service Networks since 2021.
Quick answers
Who was awarded contract 36C26226N0373?
36C26226N0373 was awarded to Travere Therapeutics, Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on February 10, 2026.
How much is contract 36C26226N0373 worth?
The government has obligated $131,523 on 36C26226N0373.
Is contract 36C26226N0373 an order under another contract?
Yes. 36C26226N0373 is a delivery order under 36F79721D0239, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26226N0373 competed?
The extent of competition for 36C26226N0373 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award